Evidence map›Paper›PMID 37159706›Full record

ArticleHeliyon2023

FeMn and FeMnAg biodegradable alloys: An

Luke Saliba, Keith Sammut, Christabelle Tonna, Foteini Pavli, Vasilis Valdramidis, Ray Gatt, Ryan Giordmaina, Liberato Camilleri, William Atanasio, Joseph Buhagiar and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Luke SalibaDepartment of Trauma, Orthopaedics and Sports Medicine, Mater Dei Hospital, Msida, MSD 2090, Malta.
Keith SammutDepartment of Trauma, Orthopaedics and Sports Medicine, Mater Dei Hospital, Msida, MSD 2090, Malta.
Christabelle TonnaDepartment of Metallurgy and Materials Engineering, University of Malta, Msida, MSD 2080, Malta.
Foteini PavliDepartment of Food Sciences and Nutrition, University of Malta, Msida, MSD 2080, Malta.
Vasilis ValdramidisDepartment of Food Sciences and Nutrition, University of Malta, Msida, MSD 2080, Malta.
Ray GattDepartment of Trauma, Orthopaedics and Sports Medicine, Mater Dei Hospital, Msida, MSD 2090, Malta.
Ryan GiordmainaDepartment of Trauma, Orthopaedics and Sports Medicine, Mater Dei Hospital, Msida, MSD 2090, Malta.
Liberato CamilleriDepartment of Statistics and Operations Research, University of Malta, Msida, MSD 2080, Malta.
William AtanasioMortuary and Anatomic Pathology Department, Mater Dei Hospital, Msida, MSD 2090, Malta.
Joseph BuhagiarDepartment of Metallurgy and Materials Engineering, University of Malta, Msida, MSD 2080, Malta.
Pierre Schembri WismayerDepartment of Anatomy, University of Malta, Msida, MSD 2080, Malta.
University of Malta · MTMater Dei Hospital · MT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iron-based biodegradable metal bone graft substitutes are in their infancy but promise to fill bone defects that arise after incidents such as trauma and revision arthroplasty surgery. Before clinical use however, a better understanding of their

Indexed as

Bacterial resistanceBiocompatibilityBiodegradable metalsCytotoxicityFeMnAgIn vivo corrosion

Identifiers

PMID37159706
PMCPMC10163621
OpenAlexW4366605371

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.